Tonix Pharmaceuticals Holding Corp.
(NASDAQ : TNXP)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc. 0.16%30.8214.1%$181.35m
HZNPHorizon Therapeutics Plc 0.53%91.485.5%$171.86m
BHCBausch Health Cos., Inc. 0.16%30.820.0%$144.85m
GWPHGW Pharmaceuticals Plc -0.03%217.936.1%$137.31m
ICLRICON plc -0.30%198.074.2%$132.85m
CTLTCatalent, Inc. 1.73%109.282.1%$126.49m
UTHRUnited Therapeutics Corp. 1.31%203.3614.1%$97.09m
JAZZJazz Pharmaceuticals Plc 0.29%161.402.3%$83.67m
SAVACassava Sciences, Inc. -1.26%41.570.0%$79.64m
ARGXargenx SE -1.09%277.960.0%$47.16m
PRGOPerrigo Co. Plc 0.92%40.586.9%$38.31m
SAGESAGE Therapeutics, Inc. -0.69%76.617.6%$35.72m
KMPHKemPharm, Inc. -10.21%9.152.0%$30.51m
PCRXPacira Biosciences, Inc. -0.37%68.259.9%$26.95m
AMRNAmarin Corp. Plc -1.17%5.931.5%$25.83m

Company Profile

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in New York, NY.